文献速递生殖医学

改良自然周期胚胎移植中黄体中期血清孕酮浓度:一项前瞻性盲法研究

Mid-luteal serum progesterone concentrations in modified natural cycles for embryo transfer: a prospective blinded study.
PubMed 文献 · Reprod Biomed Online · 2025-07-22

本研究在西班牙IVIRMA Valencia中心前瞻性盲法纳入241例接受改良自然周期冻融胚胎移植的不孕患者,排卵触发后给予黄体期支持,于移植日测定血清孕酮。结果显示孕酮浓度普遍充足,且各孕酮四分位组间持续妊娠率与活产率均无显著差异,多因素回归亦未发现孕酮与持续妊娠显著相关。

要点

  • 改良自然周期冻融胚胎移植中,移植日血清孕酮平均26.2±9.0 ng/ml,99%患者超过10 ng/ml。
  • 孕酮四分位组间持续妊娠率无显著差异(P=0.74),活产率亦相当(P=0.66)。
  • 多因素回归显示黄体中期孕酮与持续妊娠无显著关联(OR 0.86,95%CI 0.40-1.85;P=0.70)。

核心结论

  • 在采用HCG触发排卵和黄体期支持的改良自然周期冻融胚胎移植中,黄体中期血清孕酮浓度普遍充足,且与妊娠结局无关。

研究设计与样本

  • 前瞻性、盲法、单中心队列研究,于2020年2月至2021年6月在西班牙IVIRMA Valencia进行。
  • 共纳入241例年龄小于50岁、BMI小于40 kg/m2、接受改良自然周期冻融胚胎移植的不孕患者。
  • 当主导卵泡≥16 mm且内膜厚度>6.5 mm时,使用重组人绒毛膜促性腺激素触发排卵。
  • 黄体期支持采用微粒化阴道孕酮200 mg每12小时一次。
  • 胚胎移植后2小时内测定血清孕酮,结果盲法保存至研究结束。

主要发现

  • 胚胎移植日血清孕酮平均值为26.2±9.0 ng/ml,99%的患者超过临床相关阈值(>10 ng/ml)。
  • 按孕酮浓度四分位分组,持续妊娠率分别为:Q1(<20.2 ng/ml)56.7%,Q2(20.2-24.8 ng/ml)47.5%,Q3(24.9-31.1 ng/ml)51.7%,Q4(>31.1 ng/ml)48.3%(P=0.74)。
  • 活产率在各组间亦相当(P=0.66)。
  • 多因素logistic回归校正临床协变量后,黄体中期血清孕酮与持续妊娠无显著关联(OR 0.86,95%CI 0.40-1.85;P=0.70)。
  • 女性年龄、卵母细胞年龄、BMI、既往移植次数、移植胚胎数、胚胎质量及卵母细胞来源均与妊娠概率无关。

临床怎么用

  • 作者认为,在此设置下常规孕酮监测似乎没有必要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does mid-luteal serum progesterone concentration influence pregnancy outcomes in modified natural cycle frozen embryo transfer (mNC-FET) with ovulation triggering and luteal phase support (LPS)? DESIGN: This prospective, blinded, single-centre cohort study was conducted at IVIRMA Valencia (Spain) between February 2020 and June 2021. A total of 241 infertile patients under 50 years old, with body mass index (BMI) <40 kg/m2, undergoing mNC-FET were included. Ovulation was triggered with recombinant human chorionic gonadotrophin when the dominant follicle measured ≥16 mm and endometrial thickness was >6.5 mm. LPS was provided with micronized vaginal progesterone 200 mg every 12 h. Serum progesterone was measured within 2 h of embryo transfer, and results were blinded until study completion. RESULTS: Mean serum progesterone on embryo transfer day was 26.2 ± 9.0 ng/ml, with 99% of patients exceeding the clinically relevant threshold (>10 ng/ml). Participants were stratified into quartiles by progesterone concentration, with no significant differences in ongoing pregnancy rates: Q1 (<20.2 ng/ml), 56.7%; Q2 (20.2-24.8 ng/ml), 47.5%; Q3 (24.9-31.1 ng/ml), 51.7%; Q4 (>31.1 ng/ml), 48.3% (P = 0.74). Live birth rates were also comparable (P = 0.66). In multivariable logistic regression, mid-luteal serum progesterone was not significantly associated with ongoing pregnancy (odds ratio 0.86, 95% CI 0.40-1.85; P = 0.70) after adjusting for clinical covariates. Female age, oocyte age, BMI, number of previous transfers, embryos transferred, embryo quality, and oocyte origin were also unrelated to pregnancy probability. CONCLUSIONS: In mNC-FET cycles with HCG triggering and LPS, mid-luteal serum progesterone concentrations were consistently adequate and not associated with pregnancy outcomes. Routine progesterone monitoring appears unnecessary in this setting.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Labarta E, Rodríguez-Varela C, Vidal C, et al. Mid-luteal serum progesterone concentrations in modified natural cycles for embryo transfer: a prospective blinded study. Reprod Biomed Online. 2025. PMID: 41219023. doi:10.1016/j.rbmo.2025.105171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。